Abstract. Hypothyroidism is often observed after radioiodine treatment in Graves' disease, but it is considered a rare complication in single hyperfunctioning thyroid nodule ('hot' nodule (P <0.001 by l og\ x=r eq-\ rank test). In conclusion, the present data provide the first evidence that coexistent thyroid autoimmunity is a significant risk factor for the development of hypothyroidism in patients with hot nodule treated with radioiodine.
Abstract. Hypothyroidism is often observed after radioiodine treatment in Graves' disease, but it is considered a rare complication in single hyperfunctioning thyroid nodule ('hot' nodule) . This concept has been recently challenged, but the available data are conflicting. In the present study we therefore assessed the development of permanent hypothyroidism in 126 patients with thyroid hot nodule treated with 131I (180 \g=m\Ci/g of estimated nodule weight, total dose 5.5\p=n-\28.9 mCi). Follow-up ranged between 1 to 11 years. Hypothyroidism was observed in 5 (4%) patients, corresponding to a cumulative incidence by life- (Nofal et al. 1966; Douglas 1973; Sridama et al. 1984; DeGroot et al. 1984) , it is generally believed that hypothyroidism occurs very rarely in patients with solitary autonomous thyroid nodules ('hot' nodule), (Skillern et al. 1962; Gorman et al. 1978 ).
The precise incidence of hypothyroidism after radioiodine therapy in patients with hot nodules cannot be clearly established from previous in¬ vestigations (Eller et Ross et al. (1984) .
In the present study we evaluated the incidence of permanent hypothyroidism in a large series of patients with hot nodule treated with 131I with particular regard to the potential role of serum thyroid autoantibodies in the development of the thyroid failure. The relevance of thyroid autoimmunity as risk factor for hypothyroidism after 131I has been studied in Graves' disease with conflicting results (Sridama et Fig. 3 . As also shown in Fig. 3 , hypothyroidism was observed in 4 (16%) of the 25 thyroid antibody positive and only in 1 (1%) of the 101 thyroid antibody negative patients (P < 0.005 by 2 test). In Fig. 4 Ross et al. 1984 ). In our study we used a relatively low dose of radioiodine similar to that employed by Ross et al. (1984) and other investigators (Eller et 
